secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quoin Pharmaceuticals, Ltd. (QNRX)
CIK:        0001671502
Form:       8-K
Filed at:   2024-09-30T23:59:59+00:00
Accession:  0001104659-24-103867
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.08, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Quoin Pharma sets 2024 AGM for Dec 5; shareholder proposals due Oct 10
----------------------------------------------------------------------

- Annual meeting scheduled for December 5, 2024, more than 30 days after last year's anniversary.
- Shareholder proposals under Rule 14a-8 must be received by October 10, 2024 for inclusion in proxy.
- Universal proxy rule notice for director nominees also due by October 10, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671502/000110465924103867/0001104659-24-103867-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671502/000110465924103867/tm2425163d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-103867

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer